Exane Derivatives’s Avon Products, Inc. AVP Stock Holding History

Exane Derivatives’s Portfolio AVP Stock Details AVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	-$4	–	689
2017 Q1	$4	Hold	1	–	–	﹤0.01%	564
2016 Q4	$5	Sell	1 -14	-93%	-$81	﹤0.01%	640
2016 Q3	$85	Sell	15 -1,132	-99%	-$5.65K	﹤0.01%	541
2016 Q2	$4.33K	Sell	1,147 -142	-11%	-$611	﹤0.01%	397
2016 Q1	$6.2K	Buy	+1,289	New	+$4.6K	﹤0.01%	437
2015 Q4	–	Sell	-1,289	Closed	-$4.19K	–	577
2015 Q3	$4.19K	Sell	1,289 -33,690	-96%	-$171K	﹤0.01%	384
2015 Q2	$219K	Buy	34,979 +6,319	+22%	+$46.9K	0.02%	206
2015 Q1	$229K	Buy	28,660 +6,666	+30%	+$55.4K	0.03%	195
2014 Q4	$206K	Buy	+21,994	New	+$227K	0.03%	210

Other funds holding AVP

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Exane Derivatives's AVP Position: Q2 2017 in Review

Exane Derivatives sold out of Avon Products, Inc. (AVP) in Q2 2017, closing a stake of 1 share — an estimated $4 sold.

Exane Derivatives first reported a position in AVP in Q4 2014 and held it in 9 quarters. The position peaked at $229K in Q1 2015. 256 funds tracked by Wall St. Rank hold AVP as of Q2 2017.

Exane Derivatives reported no remaining Avon Products, Inc. position as of Q2 2017 after selling out during the quarter.
Exane Derivatives sold 1 Avon Products, Inc. share in Q2 2017, an estimated $4.
Exane Derivatives first reported a position in Avon Products, Inc. in Q4 2014 and held it in 9 quarters.
Exane Derivatives's Avon Products, Inc. position peaked at $229K in Q1 2015.
256 funds tracked by Wall St. Rank held Avon Products, Inc. as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.